You are here: Industry Insights > teva

News List

Teva spared payout to GSK over patent infringement dispute pharmafile
March 30, 2018
Teva has been spared a sizeable payout to GlaxoSmithKline after a federal judge overturned a US jury verdict demanding that the Israeli firm hand over $235 million in damages related to infringement of one of the latter’s patents.
Teva Announces the Launch of a Generic Version of ALOXI® in the United States biospace
March 26, 2018
Teva Pharmaceuticals Industries Ltd., (NYSE: TEVA) today announced the launch of a generic version of ALOXI®1 (palonosetron HCI) injection, 0.25 mg/5 mL, in the United States
Teva Canada Announces the Launch of C ACT Methylphenidate ER Tablets biospace
March 23, 2018
Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application for CACT Methylphenidate ER® tablets, the generic version of CConcerta®
Teva denies wrongdoing in Cephalon pay-to-delay deal hearing pharmafile
March 15, 2018
Teva has denied allegations from the European Commission (EC) that it engaged in illegal anti-competitive pay-to-delay tactics to maintain its market share in the sleep disorder drug space at a hearing this week, it has emerged.
Delays in drug approval cause more problems for Teva pharmaceutical-business
February 12, 2018
Teva has announced that it might encounter delays in the approval of a highly-anticipated migraine drug, causing a further slump in its share prices.
ProBioGen and TEVA Sign License Agreement on Human Artificial Lymph Node Technology contractpharma
February 08, 2018
Research License Agreement on Unique Technology to Assess Drug Effects on the Immune System in Vitro
Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital biospace
February 02, 2018
Teva today announced it has completed the sale of a portfolio of products within its global women’s health business across contraception, fertility, menopause and osteoporosis for $703 million in cash.
Apotex President resigns amidst Founder's murder and allegations of accepting Teva secrets pharmafile
January 31, 2018
Following the alleged murder of its founder Barry Sherman and his wife in December last year, Canada’s largest generic drug producer Apotex has now lost its President and CEO, as Jeremy Desai resigns effective immediately, to “pursue other opportunities.
Top 6 Generic Drug Companies to Work For biospace
January 25, 2018
At one time the generic drug market was fragmented, but over the last several years it has consolidated significantly.
Teva’s subcutaneous asthma drug fails in PhIII pharmatimes
January 24, 2018
Teva’s quest to expand approval of its respiratory drug Cinquair/Cinqaero with a new mode of delivery has hit a snag, after two late-stage studies failed to hit their targets.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page